$VVOS

3 stories mentioning VVOSUpdated just now

Every FINWIRES story that references VVOS, newest first.

Sector Update: Healthcare Stocks Rise Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.9% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.8%.The iShares Biotechnology ETF (IBB) climbed 1.7%.In corporate news, AbbVie (ABBV) has agreed to acquire Apogee Therapeutics (APGE) in an all-cash deal worth about $10.9 billion, as the drugmaker looks to boost its immunology portfolio and accelerate its clinical presence in the respiratory segment. AbbVie shares jumped past 6%, and Apogee surged 46%.Regenxbio (RGNX) shares jumped 18% after it said the US Food and Drug Administration has agreed on the next steps for a potential accelerated approval of Navsunli, its experimental gene therapy for Mucopolysaccharidosis II, following discussions related to its appeal of a complete response letter issued in February.Jaguar Health (JAGX) shares climbed 16% after the firm said Monday its board has started a process to explore strategic alternatives to maximize shareholder value.Vivos Therapeutics (VVOS) shares fell 14% after it said Monday it has extended its strategic financing agreement with Streeterville Capital through Aug. 31, giving it additional time to complete planned capital-raising efforts.

$ABBV$APGE$JAGX$RGNX$VVOS

Wire12d ago

Vivos Therapeutics Enters Collaboration With Florida Firm to Treat Cardiovascular Patients

Vivos Therapeutics (VVOS) said Wednesday it has signed a collaboration agreement with Florida-based South Palm Cardiovascular Associates to support the formation and operation of AIM Florida.AIM Florida is a management services organization that will provide diagnostic and treatment services for cardiovascular disease patients who also suffer from obstructive sleep apnea and insomnia, the company said.AIM Florida's operating plan calls for the initial establishment of a sleep optimization team to serve about 250 patients a month and generate more than $6 million a year, with contribution margins of nearly 50% once fully deployed, Vivos said.More teams are expected to be added over time to meet projected demand, the company said.

$VVOS

Sectors17d ago

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks rose late Friday afternoon with the NYSE Healthcare Index increasing 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.7%.The iShares Biotechnology ETF (IBB) declined 1.6%.In corporate news, Haemonetics (HAE) updated its financial reporting structure and will transition to two segments from three starting in Q1 fiscal 2027. The stock rose 1.8%.BioCardia (BCDA) received confirmation from the US Food and Drug Administration that its ongoing trial may support a premarket approval of the CardiAMP Cell Therapy System for the treatment of ischemic heart failure with reduced ejection fraction. BioCardia shares climbed 23%.CareCloud (CCLD) said shareholders approved all proposals put forward at the annual investor meeting on Thursday, including the re-election of Mahmud Haq and Cameron Munter to the board. CareCloud shares fell 1.5%.Vivos Therapeutics (VVOS) entered a deal with its senior secured lender, Streeterville Capital, to exchange up to $4.5 million of its outstanding debt for a combination of perpetual, nonconvertible preferred stock and shares. Vivos shares climbed 27%.

$BCDA$CCLD$HAE$VVOS

Track with the FINWIRES app suite

FolioX

Track VVOS in your portfolio

WheelAI

Analyze VVOS options with the wheel strategy

StockInsider

See market sentiment on VVOS